Literature DB >> 12525637

Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells.

Richard W Hardy1, Joseph Marcotrigiano, Keril J Blight, John E Majors, Charles M Rice.   

Abstract

A number of hepatitis C virus (HCV) proteins, including NS5B, the RNA-dependent RNA polymerase, were detected in membrane fractions from Huh7 cells containing autonomously replicating HCV RNA replicons. These membrane fractions were used in a cell-free system for the analysis of HCV RNA replication. Initial characterization revealed a reaction in which the production of replicon RNA increased over time at temperatures ranging from 25 to 40 degrees C. Heparin sensitivity and nucleotide starvation experiments suggested that de novo initiation was occurring in this system. Both Mn2+ and Mg2+ cations could be used in the reaction; however, concentrations of Mn2+ greater than 1 mM were inhibitory. Compounds shown to inhibit recombinant NS3 and NS5B activity in vitro were found to inhibit RNA synthesis in the cell-free system. This system should be useful for biochemical analysis of HCV RNA synthesis by a multisubunit membrane-associated replicase and for evaluating potential antiviral agents identified in biochemical or cell-based screens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525637      PMCID: PMC140877          DOI: 10.1128/jvi.77.3.2029-2037.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Secondary structure determination of the conserved 98-base sequence at the 3' terminus of hepatitis C virus genome RNA.

Authors:  K J Blight; C M Rice
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Complete replication in vitro of tobacco mosaic virus RNA by a template-dependent, membrane-bound RNA polymerase.

Authors:  T A Osman; K W Buck
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

Review 3.  Hepatitis C: the clinical spectrum of disease.

Authors:  J H Hoofnagle
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

4.  Detection of hepatitis C virus helicase activity using the scintillation proximity assay system.

Authors:  K Kyono; M Miyashiro; I Taguchi
Journal:  Anal Biochem       Date:  1998-03-15       Impact factor: 3.365

5.  Initiation of (-)-strand RNA synthesis catalyzed by the BMV RNA-dependent RNA polymerase: synthesis of oligonucleotides.

Authors:  J H Sun; S Adkins; G Faurote; C C Kao
Journal:  Virology       Date:  1996-12-01       Impact factor: 3.616

6.  Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus.

Authors:  P Gallinari; D Brennan; C Nardi; M Brunetti; L Tomei; C Steinkühler; R De Francesco
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

7.  Mechanistic analysis of RNA synthesis by RNA-dependent RNA polymerase from two promoters reveals similarities to DNA-dependent RNA polymerase.

Authors:  S Adkins; S S Stawicki; G Faurote; R W Siegel; C C Kao
Journal:  RNA       Date:  1998-04       Impact factor: 4.942

8.  Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity.

Authors:  V Lohmann; F Körner; U Herian; R Bartenschlager
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

9.  Template-dependent initiation of Sindbis virus RNA replication in vitro.

Authors:  J A Lemm; A Bergqvist; C M Read; C M Rice
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region.

Authors:  T Yamashita; S Kaneko; Y Shirota; W Qin; T Nomura; K Kobayashi; S Murakami
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

View more
  27 in total

Review 1.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

2.  Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay.

Authors:  Donald R O'Boyle; Peter T Nower; Julie A Lemm; Lourdes Valera; Jin-Hua Sun; Karen Rigat; Richard Colonno; Min Gao
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Endocytic Rab proteins are required for hepatitis C virus replication complex formation.

Authors:  David Manna; Jason Aligo; Chenjia Xu; Wei Sun Park; Hasan Koc; Won Do Heo; Kouacou V Konan
Journal:  Virology       Date:  2009-12-16       Impact factor: 3.616

4.  Dinucleotide analogues as novel inhibitors of RNA-dependent RNA polymerase of hepatitis C Virus.

Authors:  Weidong Zhong; Haoyun An; Dinesh Barawkar; Zhi Hong
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

5.  Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication.

Authors:  Paul Targett-Adams; Steeve Boulant; John McLauchlan
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

6.  Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies.

Authors:  Christopher J Carbone; Hui Zheng; Sabyasachi Bhattacharya; John R Lewis; Alexander M Reiter; Paula Henthorn; Zhong-Yin Zhang; Darren P Baker; Radha Ukkiramapandian; Kendra K Bence; Serge Y Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

7.  Allelic variation in the hepatitis C virus NS4B protein dramatically influences RNA replication.

Authors:  Keril J Blight
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

8.  Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly.

Authors:  Kevin C Klein; Stephen J Polyak; Jaisri R Lingappa
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication.

Authors:  Peiyong Huang; Dane A Goff; Qi Huang; Anthony Martinez; Xiang Xu; Scott Crowder; Sarkiz D Issakani; Emily Anderson; Ning Sheng; Philip Achacoso; Ann Yen; Todd Kinsella; Ihab S Darwish; Rao Kolluri; Hui Hong; Kunbin Qu; Emily Stauffer; Eileen Goldstein; Rajinder Singh; Donald G Payan; H Henry Lu
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

10.  A genetic interaction between hepatitis C virus NS4B and NS3 is important for RNA replication.

Authors:  Anne M Paredes; Keril J Blight
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.